Skip survey header

OPA COVID-19 Therapeutics Resource Survey

OPA would like to know how to help your pharmacy team prepare to provide COVID-19 therapeutics to your patients. Please provide your feedback below. 

Note: Any resources created will be provided at special membership rates. Non-members can consider becoming a member of OPA to receive this benefit and put OPA to work for you! 
4. Do you need training resources for therapeutic considerations for Paxlovid and Molnupiravir? (drug-drug interactions, exclusion and inclusion criteria, special populations dosing, etc.) 
5. Do you need training resources for modifying workflow to allow the pharmacy team to educate patients on COVID-19 therapeutics? (examples: counseling pearls, patient observation requirements, etc.)